BRCA1 and familial pancreatic carcinoma: Goldstein et al. observed that patients with pancreatic cancer and mutations in CHEK2 gene and other genes responsible for DNA damage repair such as: ATM, BRCA1/2, CDKN2A, ERCC4 and PALB2 were characterized with better survival than patients without mutations [21].